David Shalowitz, MD, MSHP, emphasizes spreading awareness of opportunistic salpingectomy across specialties while grounding its use in shared decision-making.
David Shalowitz, MD, MSHP, describes how OB-GYNs can collaborate with non-gynecologic surgeons to extend salpingectomy and reduce ovarian cancer risk during other abdominal procedures.
David Shalowitz, MD, MSHP, explains that stronger effectiveness and safety data in average-risk patients drove ACOG's strengthened salpingectomy recommendation.
The FDA office of Women's Health and Center for Drug Evaluation and Research and hosting a public workshop with a focus on testosterone use in menopausal women.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, weighs his own experience with pellet therapy against guideline evidence, then he and Maria Uloko, MD, close with candid advice for clinicians too afraid of hormones to start prescribing.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, and Maria Uloko, MD, walk through real-world dosing, cost workarounds, and the labs that actually matter for safety and efficacy.